Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3.

de la Fuente RL, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Gundersen T, Nilsen DW.

Scand Cardiovasc J. 2013 Apr;47(2):69-79. doi: 10.3109/14017431.2012.747220. Epub 2012 Dec 12.

PMID:
23127172
2.

(n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome.

Aarsetoey H, Pönitz V, Grundt H, Staines H, Harris WS, Nilsen DW.

J Nutr. 2009 Mar;139(3):507-13. doi: 10.3945/jn.108.096446. Epub 2009 Jan 21.

PMID:
19158216
3.

Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients.

Harris WS, Reid KJ, Sands SA, Spertus JA.

Am J Cardiol. 2007 Jan 15;99(2):154-8. Epub 2006 Nov 17.

PMID:
17223410
4.

Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome.

Lillpopp L, Tzikas S, Ojeda F, Zeller T, Baldus S, Bickel C, Sinning CR, Wild PS, Genth-Zotz S, Warnholtz A, Lackner KJ, Münzel T, Blankenberg S, Keller T.

Am J Cardiol. 2012 Nov 1;110(9):1225-30. doi: 10.1016/j.amjcard.2012.06.020. Epub 2012 Jul 18.

PMID:
22818785
5.

Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome.

Mjelva OR, Brügger-Andersen T, Pönitz V, Grundt H, Kontny F, Staines H, Nilsen DW.

Scand Cardiovasc J. 2013 Apr;47(2):88-97. doi: 10.3109/14017431.2013.764571. Epub 2013 Feb 13.

PMID:
23406538
6.

Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.

Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, Barth JH, Hall AS.

J Am Coll Cardiol. 2010 Jun 8;55(23):2590-8. doi: 10.1016/j.jacc.2009.12.062.

7.
8.

Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.

Manzano-Fernández S, López-Cuenca A, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F.

Am J Cardiol. 2012 Nov 1;110(9):1240-8. doi: 10.1016/j.amjcard.2012.06.027. Epub 2012 Jul 19.

PMID:
22818840
9.

Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain.

Lerakis S, McLean DS, Anadiotis AV, Janik M, Oshinski JN, Alexopoulos N, Zaragoza-Macias E, Veledar E, Stillman AE.

J Cardiovasc Magn Reson. 2009 Sep 21;11:37. doi: 10.1186/1532-429X-11-37.

10.

A new predictor of risk for sudden cardiac death.

Jabbar R, Saldeen T.

Ups J Med Sci. 2006;111(2):169-77.

PMID:
16961172
11.

Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.

Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B.

Am Heart J. 2010 Jul;160(1):88-94. doi: 10.1016/j.ahj.2010.05.002.

PMID:
20598977
12.
13.

Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.

Devore EE, Grodstein F, van Rooij FJ, Hofman A, Rosner B, Stampfer MJ, Witteman JC, Breteler MM.

Am J Clin Nutr. 2009 Jul;90(1):170-6. doi: 10.3945/ajcn.2008.27037. Epub 2009 May 27.

14.

C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room.

Magadle R, Weiner P, Beckerman M, Berar-Yanay N.

Clin Cardiol. 2002 Oct;25(10):456-60.

15.

Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome.

Nishizaki Y, Shimada K, Tani S, Ogawa T, Ando J, Takahashi M, Yamamoto M, Shinozaki T, Miyauchi K, Nagao K, Hirayama A, Yoshimura M, Komuro I, Nagai R, Daida H.

Am J Cardiol. 2014 Feb 1;113(3):441-5. doi: 10.1016/j.amjcard.2013.10.011. Epub 2013 Nov 7.

PMID:
24326273
16.

Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.

Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, Hall AS; EMMACE-2 Investigators.

J Am Coll Cardiol. 2007 Nov 20;50(21):2061-7. Epub 2007 Nov 5.

17.

B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina.

León de la Fuente R, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Gallo P, Grundt H, Staines H, Nilsen DW.

BMC Cardiovasc Disord. 2011 Sep 29;11:57. doi: 10.1186/1471-2261-11-57.

18.

N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.

Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.

J Am Coll Cardiol. 2008 Mar 25;51(12):1188-95. doi: 10.1016/j.jacc.2007.11.054.

19.

Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.

Iversen KK, Dalsgaard M, Teisner AS, Schoos M, Teisner B, Nielsen H, Clemmensen P, Grande P.

Am J Cardiol. 2009 Dec 1;104(11):1465-71. doi: 10.1016/j.amjcard.2009.07.017.

PMID:
19932776
20.

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.

Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM; SYNERGY Trial Investigators.

J Gen Intern Med. 2008 Mar;23(3):310-6. doi: 10.1007/s11606-007-0498-4. Epub 2008 Jan 15.

Supplemental Content

Support Center